Abstracts can only be submitted online and MUST be submitted BEFORE 1 APRIL 2017 23:59 hrs CET. THIS DEADLINE WILL BE STRICTLY ENFORCED, as will be the regulations given below. The EASD office will notify the presenting (= first named) author when the abstracts with the status "complete" are forwarded for anonymous review.
Submission of Abstracts
The following is a brief overview of the abstract submission process. Please read carefully the DETAILED ABSTRACT SUBMISSION GUIDELINES before you begin the abstract submission process.
It is not permitted to submit work that has been published and/or is likely to be published before the EASD Abstract submission deadline (1 April 2017, 23:59 hrs. CET). The Programme Committee has the right to remove an abstract if this contains data that has already been published. However, EASD accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings (e.g. ADA, DDG). An author submitting or presenting work that has been published in a journal before the EASD Abstract submission deadline (1 April 2017, 23:59hrs CET) will be banned from presenting data at the EASD Meetings for three years.
Abstracts submitted on Human Studies:
The box must be marked stating that the study has been reviewed by the Local Ethics Committee and that it has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration (see World Medical Association: www.wma.net).
Abstracts submitted on Animal Studies:
The box must be marked stating that the study has been carried out along the “Principles of laboratory animal care” (NIH Publication no. 85-23, revised 1985) and according to the national law, if applicable.
Selection of abstracts for the Scientific Programme is made anonymously. THE ABSTRACT MUST BE SUBMITTED as follows:
Each author can be listed ONLY ONCE as the PRESENTING author (presenting author is always the first named author in the author block) on ONE (1) abstract. Each additional abstract will be removed from the system and will not be forwarded to the Review Committee. Additional abstracts will not be reviewed. Presenting authors may be co-authors of other abstracts. It is mandatory that the presenting author of any abstract accepted for presentation attends the 53rd EASD Annual Meeting 2017 to present his / her paper. Failure to do so, without prior or adequate explanation sent to the EASD Office by e-mail, may result in the author or the institution being banned from presenting abstracts for the next three years.
Abstracts are welcome from non-members of EASD. Please refer to the Registration section of this General Information, regarding the date by which authors must become members of EASD in order to qualify for preferential registration fees. These regulations will be strictly enforced.
The abstract must be submitted in English. New authors should create an account using a login name and a password. With this information they can revise the submission as often as required, make changes, additions, amendments, change/add/delete authors, copy special characters easily into the text, re-write the abstract or copy and paste the text in the corresponding boxes. All this is possible until the Abstract Submission Deadline: 1 April 2017 23:59 hrs CET. After this date the submission site will be closed. *IMPORTANT!: Always double check that the “complete” status of your submitted abstract has NOT been affected after having edited it.
CHANGES TO THE CONTENT AND/OR THE AUTHOR BLOCK OF THE SUBMITTED ABSTRACT WILL NOT BE ACCEPTED after the submission deadline.
Your abstract submission must adhere the following structure:
The maximum number of characters is 3,200 (excl. spaces) including the title and the author block. The title should be short (maximum 150 characters).
Please enter your name and the names of co-authors as given in the example below. Start each name with a capital letter and continue in lower case, do not enter names/affiliations all in capital letters.
First Name: John
2nd Initial: J
3rd Initial: R
Last Name: Macleod
The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims:, Materials and methods:, Results: and Conclusion:). The abstract structuring words are fixed for each abstract text box. One or two sentences should describe the methods, and any aspects of methodology (e.g. use of control groups, randomisation, patient selection, assay variation). The sentences stating the results must include hard data, including statistical analysis.
It is allowed to include only one table OR one graph to your abstract, but 400 characters will be deducted from the maximum number of characters allowed. Tables must be uploaded as an image; so you must create your table and convert it into an image in order to include it in your abstract. You can edit your table or graph and then replace it, or delete it until the submission deadline of 1 April 2017, 23:59 hrs CET. Do not enter both (a table and a graph) in the same image file; also, do not create and upload multi panel images. When creating a table, do not exceed a number of 10 columns and 12 rows!
References are not allowed.
For drugs exclusively generic names should be used (no trademarks).
A list of approved abbreviations and units of expression for use without definition appears in DIABETOLOGIA: http://www.diabetologia-journal.org/webpages/abbreviations.html
Grant/Support information must be entered into its designated field.
Where applicable, the Clinical Trial Registration Number must be entered into its designated field; not in the abstract body.
Only one keyword can be selected.
Abstracts CANNOT be submitted as an e-mail attachment.
A signed copy of the final version of the abstract must be sent ONLY per e-mail as PDF file attachment to: firstname.lastname@example.org by 9 April 2017 23:59 hrs CET.
In case of questions, or if you have not received a reply by 14 April 2017, please call: +49-211-75 84 69 0 or contact email@example.com.
Abstract submission deadline 2017-06-19